SCOTTSDALE, Ariz., March 2, 2016 /PRNewswire/ -- On March 18 and 19, 2016, the Arizona Myeloma Network (AzMN) www.azmyelonanetwork.org will collaborate with the local and national medical community to host its 10th Annual Myeloma Research Roundtable: Next Generation Immunotherapy & Launching Moon Shot for Cancer and its Annual Living with Myeloma Conference Immunotherapy I MoonShot I Cure at the Chaparral Suites Ballroom located at 5001 N. Scottsdale Road in Scottsdale, Arizona.
The research roundtable draws in over 100 attendees each year including renowned clinicians, researchers, scientists, pharmacists, bioscience professionals and myeloma specialists. It is designed to present the latest research and discoveries surrounding myeloma. Attendees will leave with an increased understanding of the value, benefits and risks of clinic trial participation by myeloma patients, as well as explore new strategies to innovate and collaborate with others within the myeloma arena. A total of five CME/CEU credits are available concluding the event for healthcare professionals.
The roundtable, moderated by Joan Koerber-Walker, President and Founder of the Az BioIndustry Association, will provide attendees the opportunity to learn from faculty speakers: Dr. Joseph Mikhael of Mayo Clinic Scottsdale, Dr. Robert Kyle of Mayo Clinic Rochester, Dr. Bart Barlogie of Mount Sinai New York, Dr. Ken Anderson of the Dana Farber Cancer Institute and Jonathan Keats, PhD of TGen, and participate in a panel discussion.
"Collaboration is key when it comes to creating life-changing and life-saving innovations, and using them to make life better for patients and the people who love them. The 10th Annual Arizona Myeloma Network Myeloma Research Roundtable brings together renowned clinicians, researchers, scientists, pharmacists, bio-science professionals, and myeloma advocates committed to doing just that," stated Joan Koerber-Walker, president and founder of the AZ BioIndustry Association, of why she proudly supports the event.
Registration for the event begins at 11:30am. The Research Roundtable will start promptly at noon with a special message from AzMN Founder and President, Barbara Kavanagh, and conclude at 5:30pm. A cocktail networking reception follows from 6 to 8pm at the Chaparral Suites Courtyard to meet the country's top doctors and medical community.
Then on Saturday, March 19th, the Arizona Myeloma Network presents its 10th Annual Living with Myeloma Conference specifically designed with the patient, caregiver and families in mind. Each year, over 300 participants attend this dynamic conference, which provides cutting edge information about the latest myeloma research and the newest and most exciting therapies for myeloma cancer patients. Faculty members from March 18th's research roundtable are scheduled to present, as well as other leading cancer groups and resources.
"We are excited to be partnering with outstanding businesses and researchers to bring a wealth of information and support resources to patients and families," says Barbara Kavanagh, Founder and President of the Arizona Myeloma Network. "Our myeloma conferences continue to be a place for those affected by myeloma to learn about this rare form of blood cancer and feel less alone."
"There have been tremendous advances in the study and treatment of myeloma over the course of the past decade. I am pleased to share the latest treatment and clinical trial options with participants of the Arizona Myeloma Network conference," said Dr. Joe Mikhael, Hematologist, Professor of Medicine of Mayo Clinic of Scottsdale, and a featured speaker at the conference.
Registration begins at 8am on Saturday, March 19th and the event concludes at 4:30pm. All Myeloma patients, caregivers and families are welcome to attend this free event which also includes a continental breakfast, buffet luncheon and resource fair.
For more information or to register for this year's conference, visit http://www.azmyelomanetwork.org or contact 623-466-6246.
About the Arizona Myeloma Network
Multiple myeloma is a complex and often misdiagnosed cancer of the bone marrow that affects plasma cells, which comprise the immune system and bone. Founded in 2004 and headquartered in Glendale, Arizona, the Arizona Myeloma Network (AzMN) is a 501(c)(3) nonprofit charity organization that conducts outreach events and education programs, with special consideration for the underserved. AzMN seeks to promote promote collaboration, awareness, education and advocacy for improved treatment and quality of life for multiple myeloma patients, their families and ALL cancer. To learn more, visit www.azmyelomanetwork.org.
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arizona-nonprofit-hosts-10th-annual-research-roundtable--living-with-myeloma-conference-in-scottsdale-300229743.html
SOURCE The Arizona Myeloma Network